GLP-1 Protocol Scheduler
GLP-1 Receptor Agonist dose escalation trajectory mapping. Algorithmic protocol adherence to minimize gastrointestinal friction. Select target molecule.
GLP-1 Schedule Protocol
mg/mL
$
Current Active Week0.25 mg
WK 1Phase: Month 1
NEXT ESCALATION: 0.5 mg in 4 Weeks (Week 5)
Supported Molecular Protocols
SemaglutideGLP-1 Receptor Agonist
Mimics the GLP-1 incretin hormone with 94% sequence homology. Once-weekly dosing via 7-day albumin-bound half-life.
15–17%Weight Loss
7 daysHalf-Life
→TirzepatideDual GIP/GLP-1 Agonist
First dual GIP + GLP-1 agonist — activates two incretin pathways simultaneously for superior fat loss and glycemic control.
Up to 22.5%Weight Loss
5 daysHalf-Life
→RetatrutideTriple GLP-1/GIP/Glucagon Agonist
Triple incretin agonist — the first to also activate the glucagon receptor, adding increased energy expenditure to the GLP-1 + GIP mechanism.
Up to 28.7%Weight Loss
6 daysHalf-Life
→